Dividend Information About McKesson: Everything You Need To Know Before Its Ex-Dividend Date of Sept 2, 2025

McKesson (MCK) has announced its upcoming dividend payment of $0.820 per share, with an ex-dividend date set for Sept 2, 2025. The dividend was declared on Jul 30, 2025, and will be distributed on Oct 1, 2025. This upcoming cash dividend represents a significant increase compared to the average of the last 10 dividend payments, which stood at approximately $0.237 per share. The last cash dividend was paid on Jul 1, 2025, at a rate of $0.710 per share. The consistent cash dividend structure highlights the company’s commitment to returning value to shareholders, with the latest payout signaling a notable jump in the dividend amount.

Recently, McKesson has been the subject of increased market activity and analyst attention. As of late, the stock has shown a 1.18% price increase, with a trading volume of $600 million recorded on Aug 29, 2025. Analysts highlighted this volume spike as a sign of heightened investor interest, despite mixed signals from technical indicators. Over the past week, Argus Research raised its price target for MCK to $772 from $766, while J.P. Morgan also increased its target to $821, maintaining a positive outlook. Institutional investors, however, have shown caution, with Kestra Advisory Services LLC reducing its stake in MCK by 7.7% in the first quarter of 2025.

Since the last update, the healthcare sector has seen key developments affecting McKesson’s strategic positioning. Healthpoint Ventures announced its plan to streamline healthcare billing using AI, reflecting broader technological advancements in the industry. Additionally, Stanford Health Care secured $424.9 million in municipal bonds for facility projects, which could boost demand for logistics and supply chain services. The U.S. Department of Health and Human Services also urged providers to revise treatment protocols for transgender youth, a move that could indirectly influence healthcare policy and operations for companies like McKesson.

McKesson remains a strong fundamental performer with a score of 9.71, supported by a high Revenue-MV ratio of 2.25 and a low Price-to-Sales ratio of 1.66. These metrics indicate that the company is undervalued and has a robust revenue base. However, technical indicators such as the Marubozu White and Long Lower Shadow suggest volatility and conflicting signals for short-term traders. The overall technical score of 3.99 advises caution, despite the strong fundamentals.

In conclusion, investors should closely monitor the upcoming dividend distribution on Oct 1, 2025, with Sept 2, 2025, being the last day to purchase shares and qualify for this dividend. Given the mixed signals from both technical and fundamental analyses, a cautious and strategic approach is recommended for those considering entry into or holding of MCK shares.